Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

BPC-157 | Peptable

Peptide record Function BPC-157 is a Signal peptide. This Peptide is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects111 Mechanism BPC-157 is a synthetic 15-amino-acid fragment of a gastric cytoprotective protein that promotes angiogenesis and tissue protection primarily by modulating VEGFR2 signaling, Src/caveolin-1–dependent eNOS activation, and nitric oxide production111 BPC-157 is a Signaling modulator. Receptor VEGFR2 (vascular endothelial growth factor receptor 2) on endothelial cells, with downstream eNOS and nitric-oxide–mediated signaling11 Length 15 amino acids Organism or Origin Synthetic peptide derived from a naturally occurring human gastric 'Body Protection Compound' isolated from human gastric juice111 Gene Not assigned in the current dataset. Sequence GEPPPGKPADDAGLV 111 Glycine, Glutamic acid, Proline, Proline, Proline, Glycine, Lysine

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Peptide record

Function

BPC-157 is a Signal peptide.

This Peptide is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects111

Mechanism

BPC-157 is a synthetic 15-amino-acid fragment of a gastric cytoprotective protein that promotes angiogenesis and tissue protection primarily by modulating VEGFR2 signaling, Src/caveolin-1–dependent eNOS activation, and nitric oxide production111

BPC-157 is a Signaling modulator.

Receptor

VEGFR2 (vascular endothelial growth factor receptor 2) on endothelial cells, with downstream eNOS and nitric-oxide–mediated signaling11

Length

15 amino acids

Organism or Origin

Synthetic peptide derived from a naturally occurring human gastric 'Body Protection Compound' isolated from human gastric juice111

Gene

Not assigned in the current dataset.

Sequence

GEPPPGKPADDAGLV 111

Glycine, Glutamic acid, Proline, Proline, Proline, Glycine, Lysine, Proline, Alanine, Aspartic acid, Aspartic acid, Alanine, Glycine, Leucine, Valine

15 residuesapprox. 1401.55 Dacharge +1 / -3 / net -2special 7 • acidic 3 • basic 1 • hydrophobic 4

Sequence-derived properties

Length

15 residues

Molecular weight

1419.57 Da

Average hydrophobicity

-0.69

Unique amino acids

8

Residue class composition

special

7 (46.7%)

hydrophobic

4 (26.7%)

acidic

3 (20%)

basic

1 (6.7%)

Charge-category composition

neutral

11 (73.3%)

negative

3 (20%)

positive

1 (6.7%)

Amino acid composition

Proline (Pro/P)

4 (26.7%)

Glycine (Gly/G)

3 (20%)

Alanine (Ala/A)

2 (13.3%)

Aspartic acid (Asp/D)

2 (13.3%)

Glutamic acid (Glu/E)

1 (6.7%)

Leucine (Leu/L)

1 (6.7%)

Lysine (Lys/K)

1 (6.7%)

Valine (Val/V)

1 (6.7%)

Sources

1BPC-157 Research — Mechanism of Action, Preclinical Studies ..., https://peptide.co/research/bpc-157/ 11BPC-157 - Wikipedia, https://en.wikipedia.org/wiki/BPC-157

Related articles

Connected topics

Follow this recovery question